4-butyrolactone has been researched along with Weight Loss in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ariza, X; Asins, G; Bentebibel, A; Cordente, AG; García, J; Gómez-Puertas, P; Gurunathan, C; Hegardt, FG; Herrero, L; López-Viñas, E; Mera, P; Sebastián, D; Serra, D; Vázquez, I | 1 |
Blancafort, A; Cufí, S; Haro, D; Marrero, PF; Oliveras, G; Puig, T; Relat, J | 1 |
Cone, RD; Liu, H; Smart, JL; Takahashi, KA | 1 |
Kim, EK; Kleman, AM; Landree, LE; Ronnett, GV; Tu, Y | 1 |
Bouchard, C | 1 |
Kuhajda, FP; Landree, LE; Ronnett, GV; Thupari, JN | 1 |
2 review(s) available for 4-butyrolactone and Weight Loss
Article | Year |
---|---|
Fatty acid metabolism, the central nervous system, and feeding.
Topics: 4-Butyrolactone; Central Nervous System; Eating; Energy Intake; Energy Metabolism; Fatty Acid Synthases; Fatty Acids; Gene Expression; Humans; Obesity; Oxidation-Reduction; Weight Loss | 2006 |
Inhibition of food intake by inhibitors of fatty acid synthase.
Topics: 4-Butyrolactone; Acetyl-CoA Carboxylase; Animals; Eating; Enzyme Inhibitors; Fatty Acid Synthases; Humans; Mice; Neuropeptide Y; Obesity; Triglycerides; Weight Loss | 2000 |
4 other study(ies) available for 4-butyrolactone and Weight Loss
Article | Year |
---|---|
C75 is converted to C75-CoA in the hypothalamus, where it inhibits carnitine palmitoyltransferase 1 and decreases food intake and body weight.
Topics: 4-Butyrolactone; Acyl Coenzyme A; Animals; Binding Sites; Body Weight; Carnitine O-Palmitoyltransferase; Eating; Female; Humans; Hypothalamus; Mice; Protein Structure, Secondary; Rats; Rats, Sprague-Dawley; Weight Loss | 2009 |
Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancer.
Topics: 4-Butyrolactone; Adenocarcinoma; Adenocarcinoma of Lung; Analysis of Variance; Animals; Apoptosis; Carnitine O-Palmitoyltransferase; Catechin; Cell Line, Tumor; Fatty Acid Synthases; Fatty Acids; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Random Allocation; Signal Transduction; Weight Loss; Xenograft Model Antitumor Assays | 2012 |
The anorexigenic fatty acid synthase inhibitor, C75, is a nonspecific neuronal activator.
Topics: 4-Butyrolactone; Action Potentials; Animals; Arcuate Nucleus of Hypothalamus; Eating; Fatty Acid Synthases; Feces; Female; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Neuropeptide Y; Patch-Clamp Techniques; Pro-Opiomelanocortin; Purkinje Cells; Weight Loss | 2004 |
C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity.
Topics: 3T3 Cells; 4-Butyrolactone; Adenosine Triphosphate; Adipocytes; Animals; Carnitine O-Palmitoyltransferase; Diet; Energy Metabolism; Enzyme Inhibitors; Epoxy Compounds; Fatty Acid Synthases; Fatty Acids; Humans; Male; Malonyl Coenzyme A; Mice; Mice, Inbred C57BL; Obesity; Oxidation-Reduction; Tumor Cells, Cultured; Weight Loss | 2002 |